Investors

2018 Press Releases

Keyword Search
2018 | 2017 | 2016 | 2015
DateTitle Download Print
02/07/18BrainStorm's NurOwn® Phase 2 ALS Clinical Trial and Biomarker Abstracts Accepted for Platform Presentations at the 70th Annual American Academy of Neurology Meeting in Los Angeles, California Printer Friendly Version
02/06/18BrainStorm Cell Therapeutics to Present at the BIO CEO & Investor Conference Printer Friendly Version
02/05/18BrainStorm Cell Therapeutics Appoints Senior Kite Executive, Anthony Polverino, Ph.D., to Board of Directors Printer Friendly Version
01/16/18BrainStorm to Present at Precision Medicine World Conference 2018 Silicon Valley on January 22 Printer Friendly Version
01/03/18BrainStorm Granted GMP Certification for a Marketing-Level Manufacturing of NurOwn® Printer Friendly Version